Taxim-O 200 (Cefixime): Uses for Typhoid, UTI & Respiratory Infections
Detailed guide on Taxim-O 200 (Cefixime oral cephalosporin): treatment for enteric typhoid fever, urinary tract infections, dosage rules, and generic...
Taxim-O 200 contains Cefixime 200mg, a third-generation oral cephalosporin antibiotic. It is widely prescribed in India for uncomplicated typhoid (Salmonella typhi), acute urinary tract infections (UTIs), gonococcal infections, and middle ear otitis media.
1. Third-Generation Cephalosporin Action
Cefixime inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). It is highly resistant to hydrolysis by a wide array of plasmid- and chromosome-mediated beta-lactamases.
2. Standard Adult Dosing (BD Schedule)
The usual adult dose is 200mg twice daily (every 12 hours) or 400mg once daily for 7 to 14 days, depending on whether the infection is a simple UTI or enteric fever.
3. Jan Aushadhi Generic Substitute
Branded Taxim-O 200 costs ~₹115 for 10 tablets. Jan Aushadhi generic Cefixime 200mg dispersible tablets cost ₹32.00 (72% savings).
Top 8 Essential Indian Medicines: Branded MRP vs. Jan Aushadhi Generic Comparison
Compare average Indian retail MRP of top branded formulations against government-certified PMBJP Jan Aushadhi bioequivalent generic prices and active salts. Verified against official PMBJP formularies, NPPA price caps, and CDSCO regulatory registries.
| Brand Name | Leading Manufacturer | Active Salt Formulation (IP) | Branded MRP | Jan Aushadhi Price | Savings % |
|---|---|---|---|---|---|
| Augmentin 625 Duo | GlaxoSmithKline Pharmaceuticals | Amoxicillin Trihydrate 500mg + Potassium Clavulanate 125mg IP | ₹220.00 | ₹58.00 | 74% |
| Dolo 650 | Micro Labs Ltd | Paracetamol (Acetaminophen) 650mg IP | ₹34.00 | ₹5.50 | 84% |
| Pantocid 40 | Sun Pharmaceutical Industries | Pantoprazole Sodium 40mg IP (Gastro-resistant) | ₹155.00 | ₹8.00 | 95% |
| Azithral 500 | Alembic Pharmaceuticals | Azithromycin Dihydrate 500mg IP | ₹132.00 | ₹24.00 | 82% |
| Glycomet 500 | USV Private Limited | Metformin Hydrochloride 500mg IP | ₹24.00 | ₹4.50 | 81% |
| Shelcal 500 | Torrent Pharmaceuticals | Elemental Calcium 500mg + Cholecalciferol (Vit D3) 250 IU IP | ₹134.00 | ₹16.00 | 88% |
| Telma 40 | Glenmark Pharmaceuticals | Telmisartan 40mg IP | ₹92.00 | ₹7.50 | 92% |
| Montair-LC | Cipla Ltd | Montelukast Sodium 10mg + Levocetirizine Dihydrochloride 5mg IP | ₹210.00 | ₹18.00 | 91% |
| Combined 8-Drug Essential Therapy Basket Total: | ₹1,001.00 | ₹141.00 | 85.9% Net Savings | ||
Frequently Asked Questions (Clinical & Regulatory)
Q1: Is Cefixime safe in penicillin-allergic individuals?
Patients with mild penicillin allergies can usually take cephalosporins safely, but those with history of severe anaphylaxis should avoid cefixime due to cross-reactivity.
Q2: Can Taxim-O 200 cure a viral throat sore?
No, cefixime is an antibacterial and will not treat viral pharyngitis.
Q3: Why must patients finish the complete prescribed course of antibiotics?
Discontinuing antibiotics prematurely upon early symptomatic relief leaves partially suppressed bacterial colonies alive. These surviving pathogens rapidly develop genetic mutation mechanisms and plasmid-mediated resistance against active pharmaceutical salts, driving Antimicrobial Resistance (AMR).
Q4: What are CDSCO Schedule H1 regulations for Indian antibiotics?
Schedule H1 drugs—including third-generation cephalosporins, carbapenems, and fluoroquinolones—require registered medical practitioner prescriptions and must be recorded by pharmacies in dedicated physical registers noting doctor and patient details, held for 3 years to curb irrational antibiotic use.
Q5: Does Jan Aushadhi generic Amoxicillin + Clavulanate provide the same bacterial clearance as Augmentin 625?
Yes. Government-certified Jan Aushadhi Amoxicillin (500mg) + Potassium Clavulanate (125mg) IP meets identical pharmacopoeial standards for beta-lactamase enzyme inhibition, delivering equivalent infection resolution at ₹58.00 vs ₹220.00 branded MRP.
This clinical guide is authored and reviewed in accordance with the regulatory standards of the Indian Pharmacopoeia (IP), Central Drugs Standard Control Organization (CDSCO) drug schedules, and Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) bioequivalence guidelines. All therapeutic recommendations and drug interaction warnings are cross-referenced with official statutory publications.
Under India's Digital Personal Data Protection (DPDP) Act, 2023, MediMatch AI functions as a data fiduciary committed to zero retention of private health identifiers. Browsing educational guides, reviewing active salt monographs, and executing search queries occur without tracking or commercial profiling. All client interactions with prescription readers or lab decoders execute ephemerally in volatile memory with zero server-side storage of protected health information (PHI). For inquiries regarding data fiduciary obligations, contact our Data Protection Officer at privacy@medimatchai.in.